Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Pensacola, FL
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Pensacola, FL
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Pensacola, FL
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Pensacola, FL
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Ponte Vedra Beach, FL
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Ponte Vedra Beach, FL
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Tampa, FL
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Tampa, FL
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Wellington, FL
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Wellington, FL
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Augusta, GA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Augusta, GA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Calhoun, GA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Calhoun, GA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Columbus, GA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Columbus, GA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Gainesville, GA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Gainesville, GA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Lawrenceville, GA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Lilburn, GA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Lilburn, GA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Savannah, GA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Savannah, GA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Stockbridge, GA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Stockbridge, GA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Stockbridge, GA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Stockbridge, GA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Chicago, IL
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Evergreen Park, IL
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Evergreen Park, IL
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Glenview, IL
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Glenview, IL
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Normal, IL
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Normal, IL
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Shiloh, IL
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Shiloh, IL
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Crown Point, IN
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Crown Point, IN
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Evansville, IN
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Evansville, IN
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Evansville, IN
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Evansville, IN
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Indianapolis, IN
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Indianapolis, IN
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Indianapolis, IN
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
West Des Moines, IA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
West Des Moines, IA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Overland Park, KA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Lexington, KY
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Lexington, KY
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Lexington, KY
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Lexington, KY
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Louisville, KY
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Louisville, KY
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Owensboro, KY
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Owensboro, KY
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Metairie, LA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Metairie, LA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Shreveport, LA
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Shreveport, LA
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Bangor, ME
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Bangor, ME
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Largo, MD
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Largo, MD
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Silver Spring, MD
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Silver Spring, MD
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
White Marsh, MD
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
White Marsh, MD
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Buckley, MI
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Buckley, MI
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Fenton, MI
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Fenton, MI
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Niles, MI
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Niles, MI
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Stevensville, MI
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Stevensville, MI
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Ypsilanti, MI
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Plymouth, MN
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Plymouth, MN
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Port Gibson, MS
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Port Gibson, MS
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Kansas City, MO
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Kansas City, MO
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Kansas City, MO
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Kansas City, MO
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Kansas City, MO
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Kansas City, MO
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Warrensburg, MO
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Warrensburg, MO
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Billings, MT
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Billings, MT
Click here to add this to my saved trials